Continuing Education Credit

This conference offers Nursing Continuing Professional Develpment (NCPD) and continuing medical education (CME). Details to follow.

Registration

The early bird registration ends on Wednesday, September 9 at 5 p.m. ET.

Registration Rates  
Type Early Bird Rate Regular Rate
ASTCT Member Rate $275 $350
Non-Member Rate $375 $450
Trainee Rate $225 $300

Register Today

Agenda

Please note, schedule is subject to change. All times listed are in Central Time. Last update: June 30, 2026. View speaker disclosures.

Day 1: Thursday, October 22
8:00 – 8:15 AM Housekeeping
8:15 – 8:55 AM Keynote: Caring For Yourself While Caring For Others 
Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO; Translational Genomics Research Institute (TGen), City of Hope Cancer Center

9:00 – 9:40 AM

Why Patients Miss CAR-T Trials: A Practical Framework for Identifying Eligible Candidates in Clinical Practice
Yan Leyfman, MD; New York Presbyterian Hospital
9:45 – 10:25 AM Quality and Safety in Transplant and Cellular Therapy: A Practical Approach to Improving Outcomes
Chris Dandoy, MD, MS; Cincinnati Children's Hospital Medical Center
10:30 – 10:45 AM Break
10:45 – 11:25 AM Cord Blood Transplantation in the Modern Era
Warren Fingrut, MD, MPH; MD Anderson

11:30 AM – 12:00 PM

GI Toxicities and Nutrition during Allogeneic Stem Cell Transplant
Tracy Farrell, PA-C; University of Colorado Anschutz
Katie Harper, MS, RD, CNSC, CSO; UC Health
12:00 – 1:00 PM Lunch - Product Theater (Sanofi)
1:00 – 1:25 PM Post Transplant TA-TMA
Leonor Perez Aquino, DNP, ApRN-C, AOCNP, TCTCN; Miami Cancer Institute
1:30 – 2:15 PM Advanced Cellular Therapy for Cancer: CAR T beyond FDA Approval
Siddhartha Ganguly, MD, FACP; Houston Methodist Hospital Neal Cancer Center
2:15 – 2:30 PM Break
2:30 – 3:10 PM GVHD Prophylaxis in 2026 - PTCy, Dose Optimization, and Emerging Combination Strategies
Nihar Desai, MD, DM; Princess Margaret Cancer Center
3:15 – 3:55 PM

Transforming Therapies for Sickle Cell Disease
Anil George, MD; Baylor College of Medicine/Texas Children's Hospital

4:00 – 4:30 PM Ethical Issues Inherent in Caring for Stem Cell Transplantation and Cellular Therapy
Joyce Neumann, PhD, APRN, AOCN, HEC-C, FAAN; The University of Texas MD Anderson Cancer Center
Day 2: Friday, October 23
Track Beginner Adult Pediatric
8:00 – 8:45 AM Keynote: Best of Tandem
Margy MacMillan, MD, MSc, FRCPC; University of Minnesota
8:45 – 9:25 AM Who Gets a Transplant? Disease, Patient and Donor Factors in Allo Transplant Candidacy
Charlotte Hughes, MD; Memorial Sloan Kettering Cancer Center 		Understanding and Comparing Eligibility for HSCT and CART for Elderly Patients (>70): The Role of Frailty, Functional Trajectories, and T Cell Fitness
Marco Ruiz, MD, MPH, MSc, MBA; Miami Cancer Institute/Florida International University 		Gene Therapy for Immunodeficiency: Are We There Yet?
Sung-Yun Pai, MD; National Cancer Institute
9:30 – 10:10 AM Conditioning Regimens
Boglarka Gyurkocza, MD; Fred Hutchinson Cancer Center 		Immunotherapies in Multiple Myeloma
Muhammad Faisal, MD; OU Health Stephenson Cancer Center 		Lineage Switch Leukemia: An Emerging Phenomenon in the Era of Immunotherapy
Sara Silbert; National Cancer Institute
10:15 – 10:30 AM Break
10:30 – 11:10 AM Going Viral: A Timeline of Infection in Transplant
Leah Yoke, PA-C, MCHS; Fred Hutchinson Cancer Center 		Case Study Review: Infectious Diseases in Hematopoietic Stem Cell Transplant
Kristin Lind, APRN-CNP; The Ohio State University 		Post-Transplant Vaccinations
Paul Carpenter; Fred Hutchinson Cancer Center
11:15 – 11:55 AM Recognizing and Managing GVHD: A Practical Guide for Clinical Care
Doris Ponce, MD, MS; Memorial Sloan Kettering Cancer Center 		Beyond Steroids: Updates in Chronic Graft versus Host Disease
Brooke Adams, PharmD, BCOP; Orlando Health Cancer Institute 		GVHD in Children: Don't Throw Out the Tried and True: Integrating Established and Emerging Therapies
Vinita Pai, PharmD, MS, BCPPS; The Ohio State University, College of Pharmacy
12:00 – 1:00 PM Lunch - Product Theater (Iovance) 
1:00 – 1:25 PM CAR T Toxicities Made Practical: A Case-Based Approach to CRS, ICANS, and Delayed Neurotoxicity
Basem William, MD, MRCP(UK), FACP; OhioHealth 		A Case of Relapsed/Refractory Diffuse Large B-cell Lymphoma: Impact of Prior CAR T-cell Therapy on Subsequent Treatment Lines
Grace Li, CRNP, AOCNP; National Cancer Institute 		TA-TMA Complicated Case Review
Samantha Newman, AC-PNP; University of Michigan
1:30 – 2:15 PM The Price of Cure: Transplant-Related Organ Toxicity in Hematopoietic Cell Transplantation
Sanja Zepcan, PharmD; Loyola University Medical Center 		Sexual Health in Adults with Cancer: Assessment, Monitoring, and Management for Healthcare Professionals
Daniel Verina, DNP, MSN, RN, ACNP-BC; Mount Sinai Medical Center 		Early Recognition and Management of Pediatric VOD/SOS After HCT: From Bedside Warning Signs to Defibrotide Decisions
Mayada Shanap, MD; King Hussein Cancer Center
2:15 – 2:30 PM Break
2:30 – 3:10 PM CAR T Decoded: Indications, Toxicities, and Real-World Practice
Gabriel Sanchez-Pettito, MD; Baylor College of Medicine 		Navigating Anti-BCMA CAR T Cell Therapy Toxicities: Recognition, Management, and Future Directions
Francesca Cottini, MD; The Ohio State University 		Pediatric CAR T Coordination from Referral Through Follow-up
Anna Sparrow, PhD, MPH, RN; Children's Hospital of Philadelphia
3:15 – 3:55 PM HLA Matching in Transplant: What Every Clinician Needs to Know
Rajdeep Das, MD, PhD; University Hospitals Cleveland Medical Center 		Disease Evaluation and Transplant Strategies for Patients with Myelofibrosis
Rachel Salit, MD; Fred Hutchinson Cancer Center 		Microbiome, HCT and CAR T
Robert Jenq, MD; City of Hope
4:00 – 4:30 PM A Practical Guide to Post-Transplant Maintenance Therapy
Olivia White, PharmD, BCOP; UT Southwestern Medical Center 		DLI: Past, Present, and Future
Emily Bauer, DNP, APRN, AGACNP-BC; University of Chicago Medicine 		From Evaluation to Infusion: Managing Psychosocial Complexity
Daniel Gaylor; Moffit